Anti-HIV Immune Serum Globulin (Human) [clinicaltrials_resource:78a409e2eb16bd2f9206b2d6c2955e1b]
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) [clinicaltrials:NCT00000751]A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children [clinicaltrials:NCT00000827]The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants [clinicaltrials:NCT00000961]Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) [clinicaltrials:NCT00002036]
intervention [clinicaltrials_vocabulary:intervention]
Anti-HIV Immune Serum Globulin (Human) [clinicaltrials_resource:78a409e2eb16bd2f9206b2d6c2955e1b]
Bio2RDF identifier
78a409e2eb16bd2f9206b2d6c2955e1b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:78a409e2eb16bd2f9206b2d6c2955e1b
intervention name [clinicaltrials_vocabulary:intervention-name]
Anti-HIV Immune Serum Globulin (Human)
identifier
clinicaltrials_resource:78a409e2eb16bd2f9206b2d6c2955e1b
title
Anti-HIV Immune Serum Globulin (Human)
@en
type
label
Anti-HIV Immune Serum Globulin ...... 409e2eb16bd2f9206b2d6c2955e1b]
@en